Package 43063-913-30

Brand: bupropion hydrochloride sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 43063-913-30
Digits Only 4306391330
Product NDC 43063-913
Product ID 43063-913_32d70888-0023-5251-e063-6294a90ab511
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-913-30)

Marketing

Marketing Status
Marketed Since 2018-12-13
Brand bupropion hydrochloride sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride SR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "32d70888-0023-5251-e063-6294a90ab511", "openfda": {"upc": ["0343063913307"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["f58ce435-b124-4519-98d8-de2d00f61b01"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-913-30)", "package_ndc": "43063-913-30", "marketing_start_date": "20181213"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "43063-913_32d70888-0023-5251-e063-6294a90ab511", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43063-913", "generic_name": "bupropion hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA079095", "marketing_category": "ANDA", "marketing_start_date": "20090702", "listing_expiration_date": "20261231"}